Lv21
180 积分 2025-01-07 加入
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
5天前
已关闭
Phase I Study: Safety and Efficacy of an Ex Vivo-Expanded Allogeneic Natural Killer Cell (MG4101) with Rituximab for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma
6天前
已完结
Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Autoimmune Diseases
12天前
已完结
Hematopoietic stem cell transplant, chimeric antigen receptor T-cells, and other cellular therapies as stepping stones toward long-term improvement in severe scleroderma and other autoimmune diseases
12天前
已完结
Prospects of Disease-Modifying Osteoarthritis Drugs
16天前
已完结
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
17天前
已完结
Novel therapeutic interventions for combating Parkinson’s disease and prospects of Nose-to-Brain drug delivery
1个月前
已完结
Phase 1 study of safety and preliminary efficacy ofintranasal transplantation of human neural stem cells (ANGE-S003) in Parkinson's disease
1个月前
已完结
Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease
1个月前
已完结
[Recommendations for diagnosis and treatment of systemic sclerosis in China]
1个月前
已完结
皖公网安备34019202002308
